デフォルト表紙
市場調査レポート
商品コード
1429022

眼科超音波検査の世界市場の評価:製品別、モダリティ別、エンドユーザー別、地域別、機会、予測(2017年~2031年)

Ophthalmic Ultrasound Market Assessment, By Product, By Modality, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日: | 発行: Market Xcel - Markets and Data | ページ情報: 英文 228 Pages | 納期: 3~5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.74円
眼科超音波検査の世界市場の評価:製品別、モダリティ別、エンドユーザー別、地域別、機会、予測(2017年~2031年)
出版日: 2024年02月20日
発行: Market Xcel - Markets and Data
ページ情報: 英文 228 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の眼科超音波検査の市場規模は、2023年の6億2,780万米ドルから2031年に11億5,858万米ドルに達し、予測期間の2024年~2031年にCAGRで7.96%の成長が見込まれています。視力障害の罹患率の上昇と、それに伴う早期かつ正確な診断の必要性により、世界の眼科超音波検査市場は急速に拡大しています。高齢化は視力障害の主因です。黄斑変性症や老眼など、加齢に伴って生じるさまざまな視力の問題を管理するには、早期診断が極めて重要です。眼科超音波検査は、外傷性眼外傷の評価、まだ視力障害を引き起こしていない小さな腫瘍を含む眼内腫瘍の有無と位置の評価、網膜剥離の評価、血管疾患の評価などの可能性を持っています。

眼科超音波検査の利点は患者に広く知られるようになり、この画像診断機器の受容が高まっています。技術の進歩、市場参入企業による製品の発売、医療支出の増加、可処分所得の増加が眼科超音波検査市場の成長に大きな役割を果たしています。さらに、社会経済的地位の低い人々向けの診断機器や、より効率的で効果的な診断アプローチの研究開発に投資するための官民企業の提携やジョイントベンチャーなど、眼科医療サービスへのアクセスを改善するための政府の支援や取り組みが、市場の成長をさらに促進しています。

視力障害の有病率の増加

世界中で視力障害が増加しているため、眼科超音波検査の需要が急増しています。眼科超音波検査は、非侵襲性と眼構造の詳細な画像を提供する能力を持ち、白内障、近視、遠視、糖尿病網膜症、緑内障、加齢黄斑変性、老眼などのさまざまな眼疾患の診断と管理に重要な役割を果たしています。WHOによると、全世界で22億人が近見または遠見の視力障害を患っています。視力障害に伴う生産性のコストは世界で年間4,110億米ドルと推定され、世界の医療制度に多大な経済的負担を強いています。視力障害の有病率は中低所得国でもっとも高くなっています。視力障害の管理には、アイウェアへのアクセスを改善し、正確な診断に向けて眼科超音波検査を使用することによる早期発見と早期介入が重要です。

眼科超音波検査の技術の進歩

超音波技術における技術革新は高いイメージング能力を可能にし、臨床医に眼構造の可視化における精度とディテールの向上を提供しています。AIと機械学習の統合により、眼疾患の迅速かつ正確な検出に対する診断精度がさらに向上しました。超音波診断機器の小型化により携帯性が向上し、ポイントオブケア診断が可能になっています。2023年6月、AIを活用した眼科超音波検査とAI効果予測バイオマーカーの世界的リーダーであるEyenukは、Topconの網膜カメラNW400を使用し、AIを活用して糖尿病網膜症を自動検出するための米国FDA認可を取得しました。この革新的な製品は、早期発見により糖尿病患者の視力を保つのに役立つ可能性があります。

政府の取り組み

眼疾患の負担の増大と先進の診断機器の必要性を認識し、多くの政府が眼科診断機器の採用を支援する医療政策と構想を策定しています。これらの診断機器の開発に対する資金援助、研究助成、補助金などのプログラムは、医療施設や開業医がこれらの機器を診療に取り入れることを奨励しています。2023年5月、National Health Service(NHS)Englandは、イングランドの患者の眼科医療サービスの待ち時間を短縮できる新しい臨床ガイダンスの実施を発表しました。この構想はまた、眼科超音波検査機器などの最新のデジタル診断機器の助けを借りて、眼科医療の診断と治療を改善することを目的としています。これにより、患者の眼科治療の速度と質が向上します。

ポータブル眼科超音波検査の成長

製品セグメントの中では、ポータブル眼科超音波検査が予測期間に急成長する見込みです。このセグメントの技術の進歩により、寝たきりの患者や緊急時にポイントオブケアサービスを提供できる軽量ポータブル機器などの先進機器が開発されています。多くの主要市場参入企業は、このセグメントの需要拡大を理解し、高精度な最新の機器を発売しています。2023年8月、Alpinion Medical Systems Co.Ltd.はポータブル超音波診断機器「X-Cube i9」を発売しました。デュアルバッテリーとプローブコネクターを装備しています。X-Cube i9は軽量で携帯性に優れ、わずか1分でセットアップが完了し、最大100時間のスタンバイモードと1時間以上のスキャンモード動作が可能です。この機器は眼科スクリーニングを提供し、早期発見と迅速な分析に役立ち、ベッドサイドでのケアを提供します。

当レポートでは、世界の眼科超音波検査市場について調査分析し、市場規模と予測、市場力学、主要企業情勢と見通しなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の眼科超音波検査市場の見通し(2017年~2031年)

  • 市場規模と予測
    • 金額
    • 数量
  • 製品別
    • A-スキャン
    • B-スキャン
    • パキメーター
    • 複合
    • 超音波生体顕微鏡法(UBM)
  • モダリティ別
    • ポータブル
    • 非ポータブル
  • エンドユーザー別
    • 病院・診療所
    • 眼科クリニック
    • 外来手術センター
    • その他
  • 地域別
    • 北米
    • 欧州
    • 南米
    • アジア太平洋
    • 中東・アフリカ
  • 市場シェア:企業別(2023年)

第5章 世界の眼科超音波検査市場の見通し:地域別(2017年~2031年)

  • 北米
    • 市場規模と予測
    • 製品別
    • モダリティ別
    • エンドユーザー別
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • イタリア
    • 英国
    • ロシア
    • オランダ
    • スペイン
    • トルコ
    • ポーランド
  • 南米
    • ブラジル
    • アルゼンチン
  • アジア太平洋
    • インド
    • 中国
    • 日本
    • オーストラリア
    • ベトナム
    • 韓国
    • インドネシア
    • フィリピン
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ

第6章 市場マッピング(2023年)

  • 製品別
  • モダリティ別
  • エンドユーザー別
  • 地域別

第7章 マクロ環境と産業構造

  • 需給分析
  • 輸出入の分析
  • バリューチェーン分析
  • PESTEL分析
  • ポーターのファイブフォース分析

第8章 市場力学

  • 成長促進要因
  • 成長抑制要因(課題、抑制要因)

第9章 規制枠組みとイノベーション

  • 臨床試験
  • 特許情勢
  • 規制当局の承認
  • イノベーション/新技術

第10章 主要企業情勢

  • マーケットリーダー上位5社の競合マトリクス
  • マーケットリーダー上位5社の市場収益分析(2023年)
  • 合併と買収/合弁事業(該当する場合)
  • SWOT分析(市場参入企業5社)
  • 特許分析(該当する場合)

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の見通し

  • Halma plc
  • DGH Technology, Inc.
  • HAI Laboratories, Inc.
  • Micro Medical Inc.
  • NIDEK Co Ltd
  • Tomey Corporation
  • AddVision Sweden AB
  • Optos GmbH
  • Carl Zeiss AG
  • Lumibird Medical Nordics AB
  • Escalon Medical Corp
  • Universal Diagnostic Solutions

第14章 戦略的推奨事項

第15章 当社について、免責事項

図表

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Ophthalmic Ultrasound Market, By Value, in USD Million, 2017-2031F
  • Figure 2. Global Ophthalmic Ultrasound Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 3. Global Ophthalmic Ultrasound Market Share (%), By Product, 2017-2031F
  • Figure 4. Global Ophthalmic Ultrasound Market Share (%), By Modality, 2017-2031F
  • Figure 5. Global Ophthalmic Ultrasound Market Share (%), By End-user, 2017-2031F
  • Figure 6. Global Ophthalmic Ultrasound Market Share (%), By Region, 2017-2031F
  • Figure 7. North America Ophthalmic Ultrasound Market, By Value, in USD Million, 2017-2031F
  • Figure 8. North America Ophthalmic Ultrasound Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 9. North America Ophthalmic Ultrasound Market Share (%), By Product, 2017-2031F
  • Figure 10. North America Ophthalmic Ultrasound Market Share (%), By Modality, 2017-2031F
  • Figure 11. North America Ophthalmic Ultrasound Market Share (%), By End-user, 2017-2031F
  • Figure 12. North America Ophthalmic Ultrasound Market Share (%), By Country, 2017-2031F
  • Figure 13. United States Ophthalmic Ultrasound Market, By Value, in USD Million, 2017-2031F
  • Figure 14. United States Ophthalmic Ultrasound Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 15. United States Ophthalmic Ultrasound Market Share (%), By Product, 2017-2031F
  • Figure 16. United States Ophthalmic Ultrasound Market Share (%), By Modality, 2017-2031F
  • Figure 17. United States Ophthalmic Ultrasound Market Share (%), By End-user, 2017-2031F
  • Figure 18. Canada Ophthalmic Ultrasound Market, By Value, in USD Million, 2017-2031F
  • Figure 19. Canada Ophthalmic Ultrasound Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 20. Canada Ophthalmic Ultrasound Market Share (%), By Product, 2017-2031F
  • Figure 21. Canada Ophthalmic Ultrasound Market Share (%), By Modality, 2017-2031F
  • Figure 22. Canada Ophthalmic Ultrasound Market Share (%), By End-user, 2017-2031F
  • Figure 23. Mexico Ophthalmic Ultrasound Market, By Value, in USD Million, 2017-2031F
  • Figure 24. Mexico Ophthalmic Ultrasound Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 25. Mexico Ophthalmic Ultrasound Market Share (%), By Product, 2017-2031F
  • Figure 26. Mexico Ophthalmic Ultrasound Market Share (%), By Modality, 2017-2031F
  • Figure 27. Mexico Ophthalmic Ultrasound Market Share (%), By End-user, 2017-2031F
  • Figure 28. Europe Ophthalmic Ultrasound Market, By Value, in USD Million, 2017-2031F
  • Figure 29. Europe Ophthalmic Ultrasound Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 30. Europe Ophthalmic Ultrasound Market Share (%), By Product, 2017-2031F
  • Figure 31. Europe Ophthalmic Ultrasound Market Share (%), By Modality, 2017-2031F
  • Figure 32. Europe Ophthalmic Ultrasound Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Ophthalmic Ultrasound Market Share (%), By Country, 2017-2031F
  • Figure 34. Germany Ophthalmic Ultrasound Market, By Value, in USD Million, 2017-2031F
  • Figure 35. Germany Ophthalmic Ultrasound Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 36. Germany Ophthalmic Ultrasound Market Share (%), By Product, 2017-2031F
  • Figure 37. Germany Ophthalmic Ultrasound Market Share (%), By Modality, 2017-2031F
  • Figure 38. Germany Ophthalmic Ultrasound Market Share (%), By End-user, 2017-2031F
  • Figure 39. France Ophthalmic Ultrasound Market, By Value, in USD Million, 2017-2031F
  • Figure 40. France Ophthalmic Ultrasound Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 41. France Ophthalmic Ultrasound Market Share (%), By Product, 2017-2031F
  • Figure 42. France Ophthalmic Ultrasound Market Share (%), By Modality, 2017-2031F
  • Figure 43. France Ophthalmic Ultrasound Market Share (%), By End-user, 2017-2031F
  • Figure 44. Italy Ophthalmic Ultrasound Market, By Value, in USD Million, 2017-2031F
  • Figure 45. Italy Ophthalmic Ultrasound Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 46. Italy Ophthalmic Ultrasound Market Share (%), By Product, 2017-2031F
  • Figure 47. Italy Ophthalmic Ultrasound Market Share (%), By Modality, 2017-2031F
  • Figure 48. Italy Ophthalmic Ultrasound Market Share (%), By End-user, 2017-2031F
  • Figure 49. United Kingdom Ophthalmic Ultrasound Market, By Value, in USD Million, 2017-2031F
  • Figure 50. United Kingdom Ophthalmic Ultrasound Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 51. United Kingdom Ophthalmic Ultrasound Market Share (%), By Product, 2017-2031F
  • Figure 52. United Kingdom Ophthalmic Ultrasound Market Share (%), By Modality, 2017-2031F
  • Figure 53. United Kingdom Ophthalmic Ultrasound Market Share (%), By End-user, 2017-2031F
  • Figure 54. Russia Ophthalmic Ultrasound Market, By Value, in USD Million, 2017-2031F
  • Figure 55. Russia Ophthalmic Ultrasound Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 56. Russia Ophthalmic Ultrasound Market Share (%), By Product, 2017-2031F
  • Figure 57. Russia Ophthalmic Ultrasound Market Share (%), By Modality, 2017-2031F
  • Figure 58. Russia Ophthalmic Ultrasound Market Share (%), By End-user, 2017-2031F
  • Figure 59. Netherlands Ophthalmic Ultrasound Market, By Value, in USD Million, 2017-2031F
  • Figure 60. Netherlands Ophthalmic Ultrasound Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 61. Netherlands Ophthalmic Ultrasound Market Share (%), By Product, 2017-2031F
  • Figure 62. Netherlands Ophthalmic Ultrasound Market Share (%), By Modality, 2017-2031F
  • Figure 63. Netherlands Ophthalmic Ultrasound Market Share (%), By End-user, 2017-2031F
  • Figure 64. Spain Ophthalmic Ultrasound Market, By Value, in USD Million, 2017-2031F
  • Figure 65. Spain Ophthalmic Ultrasound Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 66. Spain Ophthalmic Ultrasound Market Share (%), By Product, 2017-2031F
  • Figure 67. Spain Ophthalmic Ultrasound Market Share (%), By Modality, 2017-2031F
  • Figure 68. Spain Ophthalmic Ultrasound Market Share (%), By End-user, 2017-2031F
  • Figure 69. Turkey Ophthalmic Ultrasound Market, By Value, in USD Million, 2017-2031F
  • Figure 70. Turkey Ophthalmic Ultrasound Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 71. Turkey Ophthalmic Ultrasound Market Share (%), By Product, 2017-2031F
  • Figure 72. Turkey Ophthalmic Ultrasound Market Share (%), By Modality, 2017-2031F
  • Figure 73. Turkey Ophthalmic Ultrasound Market Share (%), By End-user, 2017-2031F
  • Figure 74. Poland Ophthalmic Ultrasound Market, By Value, in USD Million, 2017-2031F
  • Figure 75. Poland Ophthalmic Ultrasound Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 76. Poland Ophthalmic Ultrasound Market Share (%), By Product, 2017-2031F
  • Figure 77. Poland Ophthalmic Ultrasound Market Share (%), By Modality, 2017-2031F
  • Figure 78. Poland Ophthalmic Ultrasound Market Share (%), By End-user, 2017-2031F
  • Figure 79. South America Ophthalmic Ultrasound Market, By Value, in USD Million, 2017-2031F
  • Figure 80. South America Ophthalmic Ultrasound Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 81. South America Ophthalmic Ultrasound Market Share (%), By Product, 2017-2031F
  • Figure 82. South America Ophthalmic Ultrasound Market Share (%), By Modality, 2017-2031F
  • Figure 83. South America Ophthalmic Ultrasound Market Share (%), By End-user, 2017-2031F
  • Figure 84. South America Ophthalmic Ultrasound Market Share (%), By Country, 2017-2031F
  • Figure 85. Brazil Ophthalmic Ultrasound Market, By Value, in USD Million, 2017-2031F
  • Figure 86. Brazil Ophthalmic Ultrasound Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 87. Brazil Ophthalmic Ultrasound Market Share (%), By Product, 2017-2031F
  • Figure 88. Brazil Ophthalmic Ultrasound Market Share (%), By Modality, 2017-2031F
  • Figure 89. Brazil Ophthalmic Ultrasound Market Share (%), By End-user, 2017-2031F
  • Figure 90. Argentina Ophthalmic Ultrasound Market, By Value, in USD Million, 2017-2031F
  • Figure 91. Argentina Ophthalmic Ultrasound Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 92. Argentina Ophthalmic Ultrasound Market Share (%), By Product, 2017-2031F
  • Figure 93. Argentina Ophthalmic Ultrasound Market Share (%), By Modality, 2017-2031F
  • Figure 94. Argentina Ophthalmic Ultrasound Market Share (%), By End-user, 2017-2031F
  • Figure 95. Asia-Pacific Ophthalmic Ultrasound Market, By Value, in USD Million, 2017-2031F
  • Figure 96. Asia-Pacific Ophthalmic Ultrasound Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 97. Asia-Pacific Ophthalmic Ultrasound Market Share (%), By Product, 2017-2031F
  • Figure 98. Asia-Pacific Ophthalmic Ultrasound Market Share (%), By Modality, 2017-2031F
  • Figure 99. Asia-Pacific Ophthalmic Ultrasound Market Share (%), By End-user, 2017-2031F
  • Figure 100. Asia-Pacific Ophthalmic Ultrasound Market Share (%), By Country, 2017-2031F
  • Figure 101. India Ophthalmic Ultrasound Market, By Value, in USD Million, 2017-2031F
  • Figure 102. India Ophthalmic Ultrasound Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 103. India Ophthalmic Ultrasound Market Share (%), By Product, 2017-2031F
  • Figure 104. India Ophthalmic Ultrasound Market Share (%), By Modality, 2017-2031F
  • Figure 105. India Ophthalmic Ultrasound Market Share (%), By End-user, 2017-2031F
  • Figure 106. China Ophthalmic Ultrasound Market, By Value, in USD Million, 2017-2031F
  • Figure 107. China Ophthalmic Ultrasound Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 108. China Ophthalmic Ultrasound Market Share (%), By Product, 2017-2031F
  • Figure 109. China Ophthalmic Ultrasound Market Share (%), By Modality, 2017-2031F
  • Figure 110. China Ophthalmic Ultrasound Market Share (%), By End-user, 2017-2031F
  • Figure 111. Japan Ophthalmic Ultrasound Market, By Value, in USD Million, 2017-2031F
  • Figure 112. Japan Ophthalmic Ultrasound Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 113. Japan Ophthalmic Ultrasound Market Share (%), By Product, 2017-2031F
  • Figure 114. Japan Ophthalmic Ultrasound Market Share (%), By Modality, 2017-2031F
  • Figure 115. Japan Ophthalmic Ultrasound Market Share (%), By End-user, 2017-2031F
  • Figure 116. Australia Ophthalmic Ultrasound Market, By Value, in USD Million, 2017-2031F
  • Figure 117. Australia Ophthalmic Ultrasound Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 118. Australia Ophthalmic Ultrasound Market Share (%), By Product, 2017-2031F
  • Figure 119. Australia Ophthalmic Ultrasound Market Share (%), By Modality, 2017-2031F
  • Figure 120. Australia Ophthalmic Ultrasound Market Share (%), By End-user, 2017-2031F
  • Figure 121. Vietnam Ophthalmic Ultrasound Market, By Value, in USD Million, 2017-2031F
  • Figure 122. Vietnam Ophthalmic Ultrasound Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 123. Vietnam Ophthalmic Ultrasound Market Share (%), By Product, 2017-2031F
  • Figure 124. Vietnam Ophthalmic Ultrasound Market Share (%), By Modality, 2017-2031F
  • Figure 125. Vietnam Ophthalmic Ultrasound Market Share (%), By End-user, 2017-2031F
  • Figure 126. South Korea Ophthalmic Ultrasound Market, By Value, in USD Million, 2017-2031F
  • Figure 127. South Korea Ophthalmic Ultrasound Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 128. South Korea Ophthalmic Ultrasound Market Share (%), By Product, 2017-2031F
  • Figure 129. South Korea Ophthalmic Ultrasound Market Share (%), By Modality, 2017-2031F
  • Figure 130. South Korea Ophthalmic Ultrasound Market Share (%), By End-user, 2017-2031F
  • Figure 131. Indonesia Ophthalmic Ultrasound Market, By Value, in USD Million, 2017-2031F
  • Figure 132. Indonesia Ophthalmic Ultrasound Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 133. Indonesia Ophthalmic Ultrasound Market Share (%), By Product, 2017-2031F
  • Figure 134. Indonesia Ophthalmic Ultrasound Market Share (%), By Modality, 2017-2031F
  • Figure 135. Indonesia Ophthalmic Ultrasound Market Share (%), By End-user, 2017-2031F
  • Figure 136. Philippines Ophthalmic Ultrasound Market, By Value, in USD Million, 2017-2031F
  • Figure 137. Philippines Ophthalmic Ultrasound Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 138. Philippines Ophthalmic Ultrasound Market Share (%), By Product, 2017-2031F
  • Figure 139. Philippines Ophthalmic Ultrasound Market Share (%), By Modality, 2017-2031F
  • Figure 140. Philippines Ophthalmic Ultrasound Market Share (%), By End-user, 2017-2031F
  • Figure 141. Middle East & Africa Ophthalmic Ultrasound Market, By Value, in USD Million, 2017-2031F
  • Figure 142. Middle East & Africa Ophthalmic Ultrasound Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 143. Middle East & Africa Ophthalmic Ultrasound Market Share (%), By Product, 2017-2031F
  • Figure 144. Middle East & Africa Ophthalmic Ultrasound Market Share (%), By Modality, 2017-2031F
  • Figure 145. Middle East & Africa Ophthalmic Ultrasound Market Share (%), By End-user, 2017-2031F
  • Figure 146. Middle East & Africa Ophthalmic Ultrasound Market Share (%), By Country, 2017-2031F
  • Figure 147. Saudi Arabia Ophthalmic Ultrasound Market, By Value, in USD Million, 2017-2031F
  • Figure 148. Saudi Arabia Ophthalmic Ultrasound Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 149. Saudi Arabia Ophthalmic Ultrasound Market Share (%), By Product, 2017-2031F
  • Figure 150. Saudi Arabia Ophthalmic Ultrasound Market Share (%), By Modality, 2017-2031F
  • Figure 151. Saudi Arabia Ophthalmic Ultrasound Market Share (%), By End-user, 2017-2031F
  • Figure 152. UAE Ophthalmic Ultrasound Market, By Value, in USD Million, 2017-2031F
  • Figure 153. UAE Ophthalmic Ultrasound Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 154. UAE Ophthalmic Ultrasound Market Share (%), By Product, 2017-2031F
  • Figure 155. UAE Ophthalmic Ultrasound Market Share (%), By Modality, 2017-2031F
  • Figure 156. UAE Ophthalmic Ultrasound Market Share (%), By End-user, 2017-2031F
  • Figure 157. South Africa Ophthalmic Ultrasound Market, By Value, in USD Million, 2017-2031F
  • Figure 158. South Africa Ophthalmic Ultrasound Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 159. South Africa Ophthalmic Ultrasound Market Share (%), By Product, 2017-2031F
  • Figure 160. South Africa Ophthalmic Ultrasound Market Share (%), By Modality, 2017-2031F
  • Figure 161. South Africa Ophthalmic Ultrasound Market Share (%), By End-user, 2017-2031F
  • Figure 162. By Product Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 163. By Modality Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 164. By End-user Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 165. By Region Map-Market Size (USD Million) & Growth Rate (%), 2023
目次
Product Code: MX11018

Global ophthalmic ultrasound market is projected to witness a CAGR of 7.96% during the forecast period 2024-2031, growing from USD 627.8 million in 2023 to USD 1158.58 million in 2031. Due to the rising incidence of vision impairment and the resulting need for early and accurate diagnosis, the global ophthalmic ultrasound market is expanding rapidly. The growing geriatric population is the primary cause of vision impairment. Early diagnosis is crucial for managing various vision problems that arise with age, including macular degeneration and presbyopia. Ophthalmic ultrasound has the potential to provide evaluation of traumatic eye injuries, assessing presence and location of intraocular tumors, including small tumors that have not yet caused visual distortion, evaluation of retinal detachment and evaluation of vascular disease.

The benefits of ophthalmic ultrasounds are becoming more widely known to patients, which has increased acceptance of these diagnostic imaging devices. Technological advancements, product launches by the market players, increased healthcare expenditure, and increasing disposable incomes are playing a major role in the growth of the ophthalmic ultrasound market. Moreover, governmental support and initiatives to improve access to eye care services, such as diagnostic appliances for low socio-economic people and public and private firm's collaborations and joint ventures to invest in research and development of the more efficient and effective diagnostic approaches, further facilitate growth in the global ophthalmic ultrasound market.

Increasing Prevalence of Vision Impairments

There has been a surge in demand for ophthalmic ultrasound due to the rising number of vision impairments worldwide. Ophthalmic ultrasound, with its non-invasive nature and ability to provide detailed images of ocular structures, plays an important role in diagnosing and managing various eye conditions such as cataracts, myopia, hyperopia, diabetic retinopathy, glaucoma, age-related macular degeneration, and presbyopia. According to WHO, 2.2 billion people are suffering from near or distance vision impairment, globally. The annual global cost of productivity associated with vision impairment is estimated to be USD 411 billion, posing a massive financial burden on global healthcare systems. The prevalence of vision impairment is most common in low-and-middle-income-countries. Early detection and early intervention by improving access to eye wear and using ophthalmic ultrasounds for accurate diagnosis are crucial in managing vision impairment.

Technological Advancements in Ophthalmic Ultrasound

Technological innovations in ultrasound technology have enabled high imaging capabilities, providing clinicians with increased accuracy and details in visualizing ocular structures. The integration of artificial intelligence (AI) and machine learning has further facilitated diagnostic accuracy for faster and accurate detection of eye conditions. The miniaturization of ultrasound devices has led to portability, allowing point-of-care diagnostics. In June 2023, Eyenuk, a global leader in AI-based ophthalmic ultrasound and AI Predictive Biomarkers, received U.S. FDA clearance to use the Topcon NW400 retinal camera to automatically detect diabetic retinopathy with the use of AI. This innovative product would help the diabetic patients to save their vision by early detection.

Government Initiatives

Recognizing the growing burden of eye diseases and the need for advanced diagnostic devices, many governments have formulated healthcare policies and initiatives to support the adoption of ophthalmic diagnostic devices. Programs for funding, grants for research, and subsidies for the development of these diagnostic devices have encouraged medical facilities and practitioners to incorporate these devices into their practices. In May 2023, National Health Service (NHS) England announced the implementation of a new clinical guidance, which could reduce waiting times for eye care services for patients in England. The initiative also aims to provide improved eye care diagnosis and treatment with the help of latest digital diagnostic appliances such as ophthalmic ultrasound devices. This will improve the speed and quality of eye care treatment for patients.

Growth in Portable Ophthalmic Ultrasound

Among the product segment, portable ophthalmic ultrasound is expected to grow faster in the forecasted period. Technological advancements in this segment have led to the development of advanced devices, such as light-weight portable devices, that can provide point of care services to the bedridden patients and during emergency locations. Many key market players understand the growing demand of this segment and are launching modern devices with high accuracy and precision. In August 2023, Alpinion Medical Systems Co. Ltd. launched their portable ultrasound device "X-Cube i9". It is equipped with dual batteries and probe connectors. X-Cube i9 is lightweight, has extended portability and sets up in just one minute, providing up to 100 hours of standby mode and more than one hour of scan mode operation. This device will provide ophthalmic screening, be beneficial in early detection and quick analysis, and provide care at the bedside.

North America Holds Largest Share in Ophthalmic Ultrasound Market

North America accounts for a significant share in the global ophthalmic ultrasound market. Robust healthcare infrastructure and advanced healthcare facilities are some of the factors which make North America a global leader in the global healthcare market. Growing awareness of the importance and benefits of screening and early diagnosis in preventing eye diseases drives the global demand for ophthalmic ultrasound. High number of eye surgeries in the region, and availability of many surgeons further leads to increased application of ophthalmic ultrasounds for constant evaluation and screening of eye diseases. There are around 20 million cataract surgeries performed each year, and the United States accounts for 3.7 million surgeries performed each year. In 2020, ophthalmologists performed 800,000 laser refractive procedures and 47,000 corneal transplants in the United States. These surgeries consistently require screening and evaluation, which drives demand in demand in this region. Moreover, key market players like DGH Technology, Inc. and Escalon Medical Corp. play a pivotal role in the availability of advanced medical devices for ophthalmology.

Future Market Scenario

The global ophthalmic ultrasound market is expected to grow in the coming years due to several factors. The global prevalence of vision impairment will increase as the population grows old. This will increase the demand for ophthalmic ultrasound due to its ability to diagnose eye-related disorders with accuracy and precision. Ophthalmic ultrasounds are cost-effective and play a crucial role in providing early intervention. The public increasingly recognizes the importance of early diagnosis and disease prevention for disorders related to the eyes. Technological advancements, government programs, increasing healthcare budgets, and collaborative partnerships between medical device companies, research institutions, and other healthcare providers are some of the factors responsible for driving the market's growth over the forecast period.

Key Players Landscape and Outlook

In the ophthalmic ultrasound market, mergers and acquisitions, partnerships, and distribution agreements are pivotal in driving the global ophthalmic ultrasound market. These alliances empower firms to adapt to each other's strengths, gain access to new markets and technologies, and pool resources for research and development. Distribution agreements enable companies to expand their market presence. These collaborative initiatives promote innovation, expedite product development, and contribute to the growth of the ophthalmic ultrasound market. In October 2022, Halma Plc. announced the acquisition of IZI Medical Products, a leading designer, manufacturer and distributor of diagnostic devices. Through this acquisition the company aims to improve the quality of its diagnostic medical devices, such as ophthalmic ultrasound devices, and enhance its market on a global level.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Ophthalmic Ultrasound Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. Value
    • 4.1.2. Volume
  • 4.2. By Product
    • 4.2.1. A- Scan
    • 4.2.2. B- Scan
    • 4.2.3. Pachymeter
    • 4.2.4. Combination
    • 4.2.5. Ultrasound bio-microscopy (UBM)
  • 4.3. By Modality
    • 4.3.1. Portable
    • 4.3.2. Non-Portable
  • 4.4. By End-user
    • 4.4.1. Hospitals & Clinics
    • 4.4.2. Ophthalmic Clinics
    • 4.4.3. Ambulatory Surgical Centers
    • 4.4.4. Others
  • 4.5. By Region
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. South America
    • 4.5.4. Asia-Pacific
    • 4.5.5. Middle East and Africa
  • 4.6. By Company Market Share (%), 2023

5. Global Ophthalmic Ultrasound Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. Value
      • 5.1.1.2. Volume
    • 5.1.2. By Product
      • 5.1.2.1. A- Scan
      • 5.1.2.2. B- Scan
      • 5.1.2.3. Pachymeter
      • 5.1.2.4. Combination
      • 5.1.2.5. Ultrasound bio-microscopy (UBM)
    • 5.1.3. By Modality
      • 5.1.3.1. Portable
      • 5.1.3.2. Non-Portable
    • 5.1.4. By End-user
      • 5.1.4.1. Hospitals & Clinics
      • 5.1.4.2. Ophthalmic Clinics
      • 5.1.4.3. Ambulatory Surgical Centers
      • 5.1.4.4. Others
    • 5.1.5. United States*
      • 5.1.5.1. Market Size & Forecast
      • 5.1.5.1.1. Value
      • 5.1.5.1.2. Volume
      • 5.1.5.2. By Product
      • 5.1.5.2.1. A- Scan
      • 5.1.5.2.2. B- Scan
      • 5.1.5.2.3. Pachymeter
      • 5.1.5.2.4. Combination
      • 5.1.5.2.5. Ultrasound bio-microscopy (UBM)
      • 5.1.5.3. By Modality
      • 5.1.5.3.1. Portable
      • 5.1.5.3.2. Non-Portable
      • 5.1.5.4. By End-User
      • 5.1.5.4.1. Hospitals & Clinics
      • 5.1.5.4.2. Ophthalmic Clinics
      • 5.1.5.4.3. Ambulatory Surgical Centers
      • 5.1.5.4.4. Others
    • 5.1.6. Canada
    • 5.1.7. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. South America
    • 5.3.1. Brazil
    • 5.3.2. Argentina
  • 5.4. Asia-Pacific
    • 5.4.1. India
    • 5.4.2. China
    • 5.4.3. Japan
    • 5.4.4. Australia
    • 5.4.5. Vietnam
    • 5.4.6. South Korea
    • 5.4.7. Indonesia
    • 5.4.8. Philippines
  • 5.5. Middle East & Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Product
  • 6.2. By Modalities
  • 6.3. By End-user
  • 6.4. By Region

7. Macro Environment and Industry Structure

  • 7.1. Supply Demand Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat from New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Clinical Trials
  • 9.2. Patent Landscape
  • 9.3. Regulatory Approvals
  • 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Halma plc
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products & Services
    • 13.1.4. Financials (As reported)
    • 13.1.5. Key Market Focus & Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. DGH Technology, Inc.
  • 13.3. HAI Laboratories, Inc.
  • 13.4. Micro Medical Inc.
  • 13.5. NIDEK Co Ltd
  • 13.6. Tomey Corporation
  • 13.7. AddVision Sweden AB
  • 13.8. Optos GmbH
  • 13.9. Carl Zeiss AG
  • 13.10. Lumibird Medical Nordics AB
  • 13.11. Escalon Medical Corp
  • 13.12. Universal Diagnostic Solutions

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14. Strategic Recommendations

15. About Us & Disclaimer